AU571430B2 - Imidazo(5,1-d) 1,2,3,5-tetrazin-4-ones - Google Patents

Imidazo(5,1-d) 1,2,3,5-tetrazin-4-ones

Info

Publication number
AU571430B2
AU571430B2 AU87493/82A AU8749382A AU571430B2 AU 571430 B2 AU571430 B2 AU 571430B2 AU 87493/82 A AU87493/82 A AU 87493/82A AU 8749382 A AU8749382 A AU 8749382A AU 571430 B2 AU571430 B2 AU 571430B2
Authority
AU
Australia
Prior art keywords
tetrazin
imidazo
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU87493/82A
Other languages
English (en)
Other versions
AU8749382A (en
Inventor
Edward Lunt
Malcolm Francis Graham Stevens
Robert Stone
Kenneth Robert Harry Wooldridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of AU8749382A publication Critical patent/AU8749382A/en
Application granted granted Critical
Publication of AU571430B2 publication Critical patent/AU571430B2/en
Assigned to CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED reassignment CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED Alteration of Name(s) in Register under S187 Assignors: MAY AND BAKER LTD.
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU87493/82A 1981-08-24 1982-08-23 Imidazo(5,1-d) 1,2,3,5-tetrazin-4-ones Expired AU571430B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24
GB8125791 1981-08-24

Publications (2)

Publication Number Publication Date
AU8749382A AU8749382A (en) 1983-03-03
AU571430B2 true AU571430B2 (en) 1988-04-21

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87493/82A Expired AU571430B2 (en) 1981-08-24 1982-08-23 Imidazo(5,1-d) 1,2,3,5-tetrazin-4-ones

Country Status (29)

Country Link
JP (1) JPS5843975A (fr)
KR (1) KR890000094B1 (fr)
AT (1) AT380256B (fr)
AU (1) AU571430B2 (fr)
BE (1) BE894175A (fr)
CA (1) CA1197247A (fr)
CH (1) CH655114A5 (fr)
DE (2) DE3231255A1 (fr)
DK (1) DK161147C (fr)
ES (1) ES8400438A1 (fr)
FI (1) FI73434C (fr)
FR (1) FR2511679A1 (fr)
GB (1) GB2104522B (fr)
GE (1) GEP19960641B (fr)
GR (1) GR76863B (fr)
HU (1) HU186107B (fr)
IE (1) IE53408B1 (fr)
IL (1) IL66606A (fr)
IT (1) IT1152505B (fr)
LT (1) LT2436B (fr)
LU (1) LU84347A1 (fr)
LV (2) LV5511A3 (fr)
NL (2) NL192739C (fr)
NZ (1) NZ201668A (fr)
OA (1) OA07174A (fr)
SE (1) SE448543B (fr)
SU (1) SU1447284A3 (fr)
UA (1) UA5971A1 (fr)
ZA (1) ZA826120B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (fr) * 1982-08-17 1986-10-31 May & Baker Ltd Nouveaux derive
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
EP2275425A1 (fr) * 2003-12-30 2011-01-19 Chemagis Ltd. Nouvelles formes cristallines de temozolomide
JP5475235B2 (ja) 2005-01-21 2014-04-16 アステックス・セラピューティクス・リミテッド 医薬化合物
AR060635A1 (es) 2006-04-27 2008-07-02 Banyu Pharma Co Ltd Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044045A1 (fr) 2006-10-12 2008-04-17 Astex Therapeutics Limited Combinaisons pharmaceutiques
CA2703489A1 (fr) 2007-10-23 2009-04-30 Banyu Pharmaceutical Co., Ltd. Derive de dihydropyrazolopyrimidinone substitue par pyridone
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
EP2367828B1 (fr) * 2008-11-24 2014-06-11 Reliance Life Sciences Pvt., Ltd. Procédé de préparation de dérivés de tétrazine
EP2403339B1 (fr) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Thérapie de combinaison anti-cancer avec un inhibiteur de akt et d'autres agents anti-cancer
WO2010149968A1 (fr) 2009-06-23 2010-12-29 Pharminox Limited Composés 3h-imidazo[5,1-d][1,2,3,5-tétrazin-4-one 3-substitués-8-substitués et leur utilisation
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
IL261721B (en) 2016-03-15 2022-07-01 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of solid tumors
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives

Also Published As

Publication number Publication date
GEP19960641B (en) 1996-11-15
FI822921A0 (fi) 1982-08-23
FI73434C (fi) 1987-10-09
DE3231255C2 (fr) 1992-02-27
GB2104522B (en) 1985-06-12
CA1197247A (fr) 1985-11-26
FR2511679A1 (fr) 1983-02-25
KR840001175A (ko) 1984-03-28
DK377882A (da) 1983-02-25
LT2436B (lt) 1994-02-15
IL66606A0 (en) 1982-12-31
HU186107B (en) 1985-06-28
BE894175A (fr) 1983-02-23
FI73434B (fi) 1987-06-30
IE822026L (en) 1983-02-24
GB2104522A (en) 1983-03-09
LV5511A3 (lv) 1994-03-10
CH655114A5 (fr) 1986-03-27
NL8203286A (nl) 1983-03-16
OA07174A (fr) 1984-04-30
UA5971A1 (uk) 1994-12-29
AT380256B (de) 1986-05-12
FR2511679B1 (fr) 1985-02-01
ATA319182A (de) 1985-09-15
GR76863B (fr) 1984-09-04
IE53408B1 (en) 1988-11-09
KR890000094B1 (ko) 1989-03-07
SE8204817L (sv) 1983-02-25
SE448543B (sv) 1987-03-02
JPH045029B2 (fr) 1992-01-30
DE19975037I2 (de) 2001-06-13
AU8749382A (en) 1983-03-03
LU84347A1 (fr) 1983-06-07
ES515176A0 (es) 1983-11-01
ES8400438A1 (es) 1983-11-01
SU1447284A3 (ru) 1988-12-23
IL66606A (en) 1987-07-31
FI822921L (fi) 1983-02-25
IT8222938A0 (it) 1982-08-23
ZA826120B (en) 1983-07-27
DK161147C (da) 1991-11-18
LV5621A3 (lv) 1994-05-10
NL990010I2 (nl) 1999-09-01
NZ201668A (en) 1985-08-16
IT1152505B (it) 1987-01-07
DE3231255A1 (de) 1983-03-03
NL192739C (nl) 1998-01-06
NL990010I1 (nl) 1999-07-01
DK161147B (da) 1991-06-03
NL192739B (nl) 1997-09-01
SE8204817D0 (sv) 1982-08-23
JPS5843975A (ja) 1983-03-14

Similar Documents

Publication Publication Date Title
AU572724B2 (en) 1,4 - diketo - pyrrolo (3,4-c) - pyrrols
AU8171282A (en) 5 oxo-thiazolo(3,2-a)azepine-3-carboxylic acids
AU548397B2 (en) N-phenylsulphonyl-n:-pyrimidinyl-and-triazinyl-ureas
AU571430B2 (en) Imidazo(5,1-d) 1,2,3,5-tetrazin-4-ones
AU548671B2 (en) 1,2-dimydro-6-methyl-2-oxo-5-(pyridinyl) nicotinonitriles
AU546185B2 (en) Levitationarium
AU8752482A (en) Imidazo (1,2-a)quinazolin-2-ones
AU547405B2 (en) Amidobenzamides
AU545678B2 (en) Sleeper-tamper
AU8553282A (en) 1(1,2,4-triazoyl/1,3-diazoyl)-2-hydroxy-(n)-phenyl-alkanes
AU529966B2 (en) Washer-dehydrator
AU549367B2 (en) 5 fluro-pgi compounds
AU531892B2 (en) 1,1-dioxopenicillanoyloxymethyl 6-(-2-amino-2-phenyl- acetamido)penicillanates
AU547692B2 (en) Trifluoromethylphenyltetrahydropyridines
AU8413382A (en) 1,4-piperizine derivatives
CS770482A2 (en) Zpusob vyroby 1 (3 benzyloxyfenyl) 1,1 dimethylheptanu
AU561252B2 (en) Dish-washer
AU547751B2 (en) Quinoline- and quinoxoline o-arylphosphetes
AU537889B2 (en) Sleeper-tamper
AU8361682A (en) 3-oxa-1-azabicyclo(4.2.0)octanes
AU2758084A (en) Pyrazolo(5,1-d)-1,2,3,5-tetrazines
AU8015682A (en) 1-substituted-6-m-propyl-8-methyl imidazo-(1,5-d)- as-triazin 4(3h-ones)
AU8717182A (en) 5(6)-phenylsulfonyloxy-benzimidazoles
AU8879882A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU533721B2 (en) 6,6-diiodopenicillanic acid

Legal Events

Date Code Title Description
NDB Extension of term for standard patent granted (sect.76)

Free format text: PRODUCT NAME: TEMOZOLOMIDE

Extension date: 20070823